A detailed history of Farther Finance Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 207 shares of RGEN stock, worth $31,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares
207
Previous 149 38.93%
Holding current value
$31,540
Previous $18.5 Million 49.3%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

BUY
$111.43 - $134.0 $6,462 - $7,772
58 Added 38.93%
207 $27.7 Million
Q2 2025

Jul 11, 2025

SELL
$108.89 - $145.23 $12,195 - $16,265
-112 Reduced 42.91%
149 $18.5 Million
Q1 2025

Apr 14, 2025

SELL
$127.24 - $174.24 $2,290 - $3,136
-18 Reduced 6.45%
261 $33.5 Million
Q4 2024

Feb 07, 2025

BUY
$123.41 - $160.92 $2,468 - $3,218
20 Added 7.72%
279 $40.2 Million
Q3 2024

Oct 28, 2024

SELL
$119.79 - $167.35 $126,977 - $177,391
-1,060 Reduced 80.36%
259 $38.5 Million
Q2 2024

Jul 31, 2024

BUY
$120.0 - $182.95 $145,200 - $221,369
1,210 Added 1110.09%
1,319 $163 Million
Q1 2024

May 13, 2024

BUY
$170.78 - $208.42 $17,931 - $21,884
105 Added 2625.0%
109 $19.9 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $9,133 - $14,828
80 Added 2000.0%
84 $15.1 Million
Q2 2023

May 13, 2024

BUY
$138.42 - $180.31 $415 - $540
3 Added 300.0%
4 $566,000
Q2 2023

Sep 12, 2023

BUY
$138.42 - $180.31 $415 - $540
3 Added 300.0%
4 $566,000
Q1 2023

May 13, 2024

SELL
$154.26 - $198.1 $12,803 - $16,442
-83 Reduced 98.81%
1 $168,000
Q1 2023

Sep 12, 2023

SELL
$154.26 - $198.1 $8,021 - $10,301
-52 Reduced 98.11%
1 $168,000
Q4 2022

Sep 11, 2023

BUY
$162.42 - $220.56 $8,608 - $11,689
53 New
53 $8.97 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.46B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.